Koshu Mahajan

Statistics

Publications

Citations

H-Index

Active since

2011

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

IQVIA (India)

Koshu Mahajan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in oxidative stress, cardiovascular pharmacology, and hypertension.

Top concepts

MedicinePhysiologyBiochemistryHypertensionPharmacologyRedox BiologyPharmacotherapyOxidative StressMolecular PharmacologyCardiovascular Pharmacology

Publications per year

2011–2021

Publications

Potent and Selective Inhibitors of Long Chain <scp>l</scp>-2-Hydroxy Acid Oxidase Reduced Blood Pressure in DOCA Salt-Treated Rats

Dinesh A. Barawkar, Ashwin Meru, Anish Bandyopadhyay et al. · ACS Medicinal Chemistry Letters · 2011 · 20 citations · Full text

Molecular Pharmacology, Hypertension, Biochemistry +14

Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands

Renée Michels, Maria de Fransesco, Koshu Mahajan et al. · Applied Health Economics and Health Policy · 2019 · 18 citations · Full text

Economic Evaluation of Cladribine Tablets in Patients With High Disease Activity–Relapsing-Remitting Multiple Sclerosis in the Kingdom of Saudi Arabia

Saeed Bohlega, Ahmed Elboghdady, Awatef Al-Johani et al. · Value in Health Regional Issues · 2021 · 11 citations

1–3 of 3